tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RIGL Stock Latest News

Rigel Pharmaceuticals’ olutasidenib shows efficacy in published AML study
The FlyRigel Pharmaceuticals’ olutasidenib shows efficacy in published AML study
12d ago
RIGL
Rigel Pharmaceuticals names Lisa Rojkjaer, M.D. as Chief Medical Officer
PremiumThe Fly
Rigel Pharmaceuticals names Lisa Rojkjaer, M.D. as Chief Medical Officer
1M ago
RIGL
SGMO
Rigel Pharmaceuticals price target raised to $4 from $3 at Citi
PremiumThe Fly
Rigel Pharmaceuticals price target raised to $4 from $3 at Citi
1M ago
RIGL
New Corporate Activity and Growth Risk for Rigel Pharmaceuticals – What’s the Latest?
PremiumCompany Announcements
New Corporate Activity and Growth Risk for Rigel Pharmaceuticals – What’s the Latest?
1M ago
RIGL
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
1M ago
RIGL
Rigel Pharmaceuticals reports Q4 EPS 0c, consensus (3c)
PremiumThe FlyRigel Pharmaceuticals reports Q4 EPS 0c, consensus (3c)
1M ago
RIGL
Options Volatility and Implied Earnings Moves Today, March 05, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 05, 2024
1M ago
BOX
JWN
Options Volatility and Implied Earnings Moves This Week, March 04 – March 07, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 04 – March 07, 2024
1M ago
FL
KR
RIGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RIGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RIGL
Rigel Pharmaceuticals price target raised to $1.75 from $1.25 at B. Riley
PremiumThe Fly
Rigel Pharmaceuticals price target raised to $1.75 from $1.25 at B. Riley
2M ago
RIGL
Rigel Pharmaceuticals Expands Oncology Portfolio with Blueprint Deal
PremiumCompany Announcements
Rigel Pharmaceuticals Expands Oncology Portfolio with Blueprint Deal
2M ago
8K
RIGL
Rigel Pharmaceuticals acquires U.S. rights to Gavreto
PremiumThe Fly
Rigel Pharmaceuticals acquires U.S. rights to Gavreto
2M ago
RIGL
Rigel Pharmaceuticals sees Q4 revenue $35.7M, consensus $29.78M
PremiumThe FlyRigel Pharmaceuticals sees Q4 revenue $35.7M, consensus $29.78M
3M ago
RIGL
Rigel Pharmaceuticals collaborating with Connect network in Phase 2 glioma trial
PremiumThe Fly
Rigel Pharmaceuticals collaborating with Connect network in Phase 2 glioma trial
3M ago
RIGL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
APLT
CDMO
Rigel Pharmaceuticals, MD Anderson partner to evaluate REZLIDHIA in AML
PremiumThe Fly
Rigel Pharmaceuticals, MD Anderson partner to evaluate REZLIDHIA in AML
4M ago
RIGL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
AQST
BCLI
Rigel Pharmaceuticals price target lowered to $1.25 from $1.75 at B. Riley
PremiumThe Fly
Rigel Pharmaceuticals price target lowered to $1.25 from $1.75 at B. Riley
5M ago
RIGL
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
5M ago
RIGL
Rigel Pharmaceuticals reports Q3 EPS (3c), consensus (7c)
PremiumThe FlyRigel Pharmaceuticals reports Q3 EPS (3c), consensus (7c)
5M ago
RIGL
Is RIGL a Buy, Before Earnings?
PremiumPre-Earnings
Is RIGL a Buy, Before Earnings?
5M ago
RIGL
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
6M ago
ATNM
PGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >